Thrombolytic therapy with streptokinase in acute ischemic stroke

New England Journal of Medicine

Volumn 335, Issue 3, 1996, Pages 145-150

  Viallet, F ^a   Bonnefoi Kyriacou, D ^a   Gayraud, D ^a   Kiegel, P ^a   Bissuel, J P ^a   Driencourt, J B ^a   Ruel, H ^a   Guillaume, L ^a   Ruffie, C ^a   Sirodot, M ^a   Valon, P ^a   Michel Bechet, L ^a   Colin, B ^a   Mourali, K ^a   Olivier, P ^a   Ziegler, B ^a   Feissel, M ^a   Cara, A ^a   Faller, J P ^a   Braun, J B ^a   Chopard, J L ^a   Berges, S ^a   Berger, E ^a   Rouanet, F ^a   Orgogozo, J M ^a   Devos, P ^a   Testard, D ^a   Bultel, J ^a   Loubrieu, G ^a   Le Bolloc'H A ^a   Fallut, M ^a   Bouniol, B ^a   Pomet, E ^a   Mocquard, Y ^a   Rouhart, F ^a   Diraison, P ^a   Goas, J Y ^a   Zagnoli, F ^a   Duriez, F ^a   Riviere B ^a   Brault, J L ^a   Colamarino, R ^a   Claveloux, P ^a   Deffond, D ^a   Durieux, A ^a   Tournilhac, M ^a   Baldauf, E ^a   Renglewicz Destgynder, C ^a   Rondepierre, P ^a   Brunet, J M ^a   Julie Coaquette V ^a   Delefosse, F ^a   Voisin, H ^a   Alibert, M ^a   Naviaux, S ^a   Campagne, J B ^a   Messin, R ^a   Bakhache, E ^a   Bouttement, C ^a   Vanrenterghem, B ^a   Masse, C ^a   Lecat, N ^a   Lenfant, F ^a   Souyris, F ^a   Lambert, P ^a   Huttin, B ^a   Gerard D ^a   Planque, E ^a   Alexandre, J L ^a   Gilet, B ^a   Limousin, P ^a   Kok, G ^a   Lizeretti, J ^a   Verier, A ^a   Delisse, B ^a   Caparros Lefebvre, D ^a   Durieu Couade, I ^a   Godefroy, O ^a   Goldstein, P ^a   Henon, H ^a   Lestavel, P ^a   Leys, D ^a   Lucas, C ^a   Mounier Vehier, F ^a   Mathe, D ^a   Clement, S ^a   Ducluzeau, R ^a   Meyran, S ^a   Demaziere, J ^a   Coppere B ^a   Ninet, J ^a   Madoux, M H Girard ^a   Gabollet, C ^a   Laplace, S ^a   Matas, O ^a   Turkie, B ^a   Gavaud Kennoz, C ^a   Lafuma, H ^a   Gallet, M ^a   Lestrevel, M ^a   Granger, J ^a   Rozand, G ^a   Crettet Pousset, G ^a   Savet, J F ^a   Cavallaro, J ^a   Mangola, B ^a   Ribier, A ^a   Rosolacci, T ^a   Neuville, V ^a   Chaussinand, J P ^a   Chanwar, J ^a   Courtois, S ^a   Masson, C ^a   Ille, O ^a   Woimant, F ^a   Amarenco, P ^a   Chabriat, H ^a   Bousser, M G ^a   Nouailhat, F ^a   Outin, H ^a   Merrer, J ^a   Neau, J P ^a   Tantot, A M ^a   Visy, J M ^a   Vaunaize, J ^a   Pinel, J F ^a   Brughgraeve, V De ^a   Deydier, A ^a   Hermouet, M ^a   Adnet Bonte, C ^a   Onnient, Y ^a   Guegan Massardier, E ^a   Tardy, B ^a   Bertrand, J C ^a   Viallon, A ^a   Lafond, P ^a   Zeni, F ^a   Page, Y ^a   Cusey, I ^a   Merienne, M ^a   Legrand, S ^a   Tranchant, C ^a   Rodier, G ^a   Faitg, R ^a   Tavernier, D ^a   Piot, P ^a   Gillon, T ^a   Sache, L ^a   Schmidt, M H ^a   Zerouali, Y ^a   Feuchere P ^a   Chollet, F ^a   Guiraud Chaumeil, B ^a   Saudeau, D ^a   Devauchelle, H ^a   Autret, A ^a   Decombe, R ^a   Rouques, C ^a   Billaud, B ^a   Rechem, M Van ^a   Kassiotis, P ^a   Legal Meigne, B ^a   Brunet Bourgin, F ^a   McInnes, G T ^a   Muir, K W ^a   Reid, J L ^a   Semple, P F ^a   Hommel, M ^a   Boissel, J P ^a   Lees, K R ^a   Cornu, C ^a   Gauthier, E ^a   Visele N ^a   Boutitie, F ^a   Jail Lard, A Serradj ^a   Noelle B ^a   Perez, S ^a   Bataille, C ^a   Bogaert, M ^a   Rascol, A ^a   Uberla K ^a   Besson, G ^a   Moulin, T ^a   Chavot, D ^a   Crepin Leblond, T ^a   Tatu, L ^a   Garnier, P ^a   Dumas, R ^a   Michel, D ^a   Perret, J ^a   Rumbach, L ^a   Ferry, S ^a   Sappori, J M ^a   Descottes, J ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; STREPTOKINASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0000945065     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607183350301     Document Type: Article

References (25)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
2. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
3. Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: does it work? Stroke 1992;23:1826-39.
4. Hommel M, Bogousslavsky J. Thrombolytics in acute cerebral ischaemia. Expert Opin Invest Drugs 1994;3:1011-20.
5. Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995;345:578-9.
6. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274: 1017-25.
7. Multicenter Acute Stroke Trial - Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995;346:1509-14.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
9. Hommel M, Boissel JP, Cornu C, et al. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet 1995;345:57.
10. The MAST Group. Protocol for the Multicenter Acute Stroke Trial-Thrombolysis study. Clin Trials Metaanal 1993;28:329-44.
11. Orgogozo JM, Asplund K, Boysen G. A unified form for neurological scoring of hemispheric stroke with motor impairment. Stroke 1992;23: 1678-9.
12. Boissel JP, Bossard N. Registry of Multicenter Clinical Trials: twelfth and thirteenth report - 1990-1991. Thromb Haemost 1992;68:752-78.
13. The OSTR Collaborative Group. The Ottawa Stroke Trials Registry Collaborative Group and the development of the Ottawa Stroke Trials Registry (OSTR). Control Clin Trials 1994;15:503-11.
14. Major ongoing stroke trials. Stroke 1994;25:1317.
15. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
16. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14(2):61-5.
17. Jaillard-Serradj A. Value of phone interview in stroke outcome assessment. Cerebrovasc Dis 1995;5:269.
18. Candelise L, Pinardi G, Aritzu E, Musicco M. Telephone interview for stroke outcome assessment. Cerebrovasc Dis 1994;4:341-3.
19. Tomura N, Uemura K, Inugami A, Fujita H, Higano S, Shishido F. Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology 1988;168:463-7.
20. Truwit CL, Barkovich AJ, Gean-Marton A, Hibri N, Norman D. Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 1990;176:801-6.
21. Tomsick TA, Brott TG, Chambers AA, et al. Hyperdense middle cerebral artery sign on CT: efficacy in detecting middle cerebral artery thrombosis. AJNR Am J Neuroradiol 1990;11:473-7.
22. Moulin T, Crépin-Leblond T, Chopard JL, Bogousslavsky J. Hemorrhagic infarcts. Eur Neurol 1994;34:64-77.
23. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INVEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994; 4:204-10.
24. Modan B, Wagener DK. Some epidemiological aspects of stroke: mortality/morbidity trends, age, sex, race, socioeconomic status. Stroke 1992; 23:1230-6.
25. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke 1994;25:1721-5.